IBA announced that the Universittklinikum Carl Gustav Carus from the Dresden Technical University, Germany, has selected IBA for the installation of a proton therapy facility. IBA will supply and install a proton therapy facility, including a gantry-equipped treatment room and a research room. The agreement includes a long term maintenance contract.
The Universittklinikum Carl Gustav Carus is a research center that, among others, is developing laser beam technology that may be used for future development of proton therapy.
"We are proud to be selected by the Universittklinikum Carl Gustav Carus, especially since both institutions plan to develop a joint R&D program that aims to develop proton therapy. We are honored to take part in this important project," said Pierre Mottet, CEO of IBA. "We are particularly excited as this new center will participate to make proton therapy more accessible to more patients across Europe."